These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 32990737)

  • 1. Clinical Screening for COVID-19 in Asymptomatic Patients With Cancer.
    Shah MA; Mayer S; Emlen F; Sholle E; Christos P; Cushing M; Hidalgo M
    JAMA Netw Open; 2020 Sep; 3(9):e2023121. PubMed ID: 32990737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of COVID-19 Screening in Cancer Patients.
    Lee LYW; Hill T; Topping O; Tilby M; Baker M; Greig J; Isherwood L; Miller R; Petrenko Y; Desai R; Field A; Kennedy B; Khan S; Kountourou A; Ndlovu S; Starkey T; Storey F; Turner L; Vaughan-Williams W; Moyler S; Preston H; Latty B; Walker S; Henderson DR; Thompson J; Jones N; Ghafoor Q; Pascoe J; Williams S; Middleton G;
    Cancer Cell; 2020 Sep; 38(3):306-307. PubMed ID: 32730750
    [No Abstract]   [Full Text] [Related]  

  • 3. [Investigación en cáncer en el contexto de la pandemia de la enfermedad por SARS-CoV-2].
    Wiesner C
    Biomedica; 2020 Jun; 40(2):217-219. PubMed ID: 32673450
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence, Characteristics, and Outcome of Asthmatic Patients With Type 2 Diseases in Hospitalized Patients With COVID-19 in Madrid, Spain.
    Barroso B; Valverde-Monge M; Cañas Jose A; Rodrigo-Muñoz JM; Gonzalez-Cano B; Villalobos-Violan V; Betancor D; Gomez-Cardeñosa A; Vallejo-Chamorro G; Baptista-Serna L; Villalobos-Vilda C; Ortega-Martin L; Gómez-López A; Sanchez-Pernaute O; Romero-Bueno F; Rodriguez-Nieto MJ; Del Pozo V; Sastre J;
    J Investig Allergol Clin Immunol; 2020; 30(5):382-384. PubMed ID: 32554336
    [No Abstract]   [Full Text] [Related]  

  • 5. Two cases of skin manifestations prior to the onset of COVID-19 respiratory symptoms.
    Altayeb A; Cordaro A; Caesar J; Vyas J; Ingram J
    Int J Dermatol; 2020 Dec; 59(12):1541-1542. PubMed ID: 33084036
    [No Abstract]   [Full Text] [Related]  

  • 6. Chilblain-like lesions during the COVID-19 pandemic: should we really worry?
    Piccolo V; Neri I; Manunza F; Mazzatenta C; Bassi A
    Int J Dermatol; 2020 Aug; 59(8):1026-1027. PubMed ID: 32496583
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening for COVID-19 in Asymptomatic Patients With Cancer in a Hospital in the United Arab Emirates.
    Al-Shamsi HO; Coomes EA; Alrawi S
    JAMA Oncol; 2020 Oct; 6(10):1627-1628. PubMed ID: 32459297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous manifestation of COVID-19 reporting from Middle-Eastern countries: A point of view!
    Abdelmaksoud A; Shakshouk H; Goldust M; Dursun R; Temiz SA; Vestita M
    Int J Dermatol; 2020 Dec; 59(12):1547-1548. PubMed ID: 33099771
    [No Abstract]   [Full Text] [Related]  

  • 9. Defining Association between COVID-19 and the Multisystem Inflammatory Syndrome in Children through the Pandemic.
    Kim YJ; Park H; Choi YY; Kim YK; Yoon Y; Kim KR; Choi EH
    J Korean Med Sci; 2020 Jun; 35(22):e204. PubMed ID: 32508068
    [No Abstract]   [Full Text] [Related]  

  • 10. [Not Available].
    Cornuz J
    Rev Med Suisse; 2020 May; 16(693):1016. PubMed ID: 32401450
    [No Abstract]   [Full Text] [Related]  

  • 11. Predictors of Refractory Coronavirus Disease (COVID-19) Pneumonia.
    Abu-Raya B
    Clin Infect Dis; 2020 Jul; 71(15):895-896. PubMed ID: 32271373
    [No Abstract]   [Full Text] [Related]  

  • 12. Biphasic Variation Over Time in Presenting Features of Patients With COVID-19.
    Jamal N; Whittier S; Carter RC; Zachariah P
    Pediatrics; 2020 Nov; 146(5):. PubMed ID: 32883805
    [No Abstract]   [Full Text] [Related]  

  • 13. Universal Testing for COVID-19 in Essential Orthopaedic Surgery Reveals a High Percentage of Asymptomatic Infections.
    Gruskay JA; Dvorzhinskiy A; Konnaris MA; LeBrun DG; Ghahramani GC; Premkumar A; DeFrancesco CJ; Mendias CL; Ricci WM
    J Bone Joint Surg Am; 2020 Aug; 102(16):1379-1388. PubMed ID: 32516279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparities in Cancer Outcomes Due to COVID-19-A Tale of 2 Cities.
    Balogun OD; Bea VJ; Phillips E
    JAMA Oncol; 2020 Oct; 6(10):1531-1532. PubMed ID: 32789508
    [No Abstract]   [Full Text] [Related]  

  • 15. Universal screening for the SARS-CoV-2 virus on hospital admission in an area with low COVID-19 prevalence.
    Sastry SR; Pryor R; Raybould JE; Reznicek J; Cooper K; Patrick A; Knowlson S; Bailey P; Godbout E; Doll M; Stevens MP; Bearman G
    Infect Control Hosp Epidemiol; 2020 Oct; 41(10):1231-1233. PubMed ID: 32698924
    [No Abstract]   [Full Text] [Related]  

  • 16. Rethinking Clinical Trials Reform During the COVID-19 Pandemic.
    Nabhan C; Choueiri TK; Mato AR
    JAMA Oncol; 2020 Sep; 6(9):1327-1329. PubMed ID: 32761101
    [No Abstract]   [Full Text] [Related]  

  • 17. A Novel Viral Epidemic Collides with an Ancient Scourge: COVID-19 Associated with Tuberculosis.
    Cutler T; Scales D; Levine W; Schluger N; O'Donnell M
    Am J Respir Crit Care Med; 2020 Sep; 202(5):748-749. PubMed ID: 32609542
    [No Abstract]   [Full Text] [Related]  

  • 18. Active and Effective Measures for the Care of Patients With Cancer During the COVID-19 Spread in China.
    Wang Z; Wang J; He J
    JAMA Oncol; 2020 May; 6(5):631-632. PubMed ID: 32236504
    [No Abstract]   [Full Text] [Related]  

  • 19. SARS-CoV-2 Serology: Much Hype, Little Data.
    Farnsworth CW; Anderson NW
    Clin Chem; 2020 Jul; 66(7):875-877. PubMed ID: 32343775
    [No Abstract]   [Full Text] [Related]  

  • 20. Oncology Care Delivery in the COVID-19 Pandemic: An Opportunity to Study Innovations and Outcomes.
    Cinar P; Cox J; Kamal A; Bickel K; Krzyzanowska M; Armitage J; Ganti AK; Ward J; Wong S; Lonial S; Bosserman L
    JCO Oncol Pract; 2020 Aug; 16(8):431-434. PubMed ID: 32463764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.